Origins of MCL genes
Tier 1, high-confidence MCL genes
23 total
| Gene | Status | First MCL study | Other lists |
|---|---|---|---|
| ATM | MCL Tier 1 | Bea et al | 1,2 |
| BIRC3 | MCL Tier 1 | Bea et al | 3–5 |
| CARD11 | MCL Tier 1 | Wu et al | 6–8 |
| CCND1 | MCL Tier 1 | Bea et al | |
| DAZAP1 | MCL Tier 1 | Pararajalingam et al | |
| EWSR1 | MCL Tier 1 | Pararajalingam et al | |
| HNRNPH1 | MCL Tier 1 | Pararajalingam et al | |
| KMT2D | MCL Tier 1 | Bea et al | 7,9–11 |
| MEF2B | MCL Tier 1 | Bea et al | 7 |
| NFKBIE | MCL Tier 1 | Pararajalingam et al | 12,13 |
| NOTCH1 | MCL Tier 1 | Bea et al | 11,14,15 |
| NOTCH2 | MCL Tier 1 | Bea et al | 11,16 |
| NSD2 | MCL Tier 1 | Bea et al | 16 |
| POT1 | MCL Tier 1 | Zhang et al | |
| RB1 | MCL Tier 1 | Zhang et al | 17 |
| S1PR1 | MCL Tier 1 | Pararajalingam et al | 18 |
| SMARCA4 | MCL Tier 1 | Nadeu et al | 2,19,20 |
| SP140 | MCL Tier 1 | Bea et al | |
| SYNE1 | MCL Tier 1 | Nadeu et al | |
| TERT | MCL Tier 1 | Nadeu et al | |
| TLR2 | MCL Tier 1 | Bea et al | 21 |
| TP53 | MCL Tier 1 | Bea et al | 7,11,22,23 |
| UBR5 | MCL Tier 1 | Pararajalingam et al | 24 |
Tier 2, low-confidence MCL genes
46 total
Tier 3, retired MCL genes
0 total
| Gene | Summary | First MCL study | Other entities | QC result |
|---|
References
1.
Braggio E, Dogan A, Keats JJ, Chng WJ, Huang G,
Matthews JM, Maurer MJ, Law ME, Bosler DS, Barrett M, Lossos IS, Witzig
TE, Fonseca R. Genomic analysis of marginal zone and lymphoplasmacytic
lymphomas identified common and disease-specific abnormalities. Mod
Pathol. 2012 May;25(5):651–660. PMCID: PMC3341516
2.
Reddy A, Zhang J, Davis NS, Moffitt AB, Love
CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg
ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W,
Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y,
Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O,
Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB,
Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava
G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn
A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T,
Rajagopalan D, Datta J, Dunson DB, Dave SS. Genetic and Functional
Drivers of Diffuse Large B Cell Lymphoma. Cell. 2017
Oct;171(2):481–494.e15. PMCID: PMC5659841
3.
Arthur SE, Jiang A, Grande BM, Alcaide M,
Cojocaru R, Rushton CK, Mottok A, Hilton LK, Lat PK, Zhao EY, Culibrk L,
Ennishi D, Jessa S, Chong L, Thomas N, Pararajalingam P, Meissner B,
Boyle M, Davidson J, Bushell KR, Lai D, Farinha P, Slack GW, Morin GB,
Shah S, Sen D, Jones SJM, Mungall AJ, Gascoyne RD, Audas TE, Unrau P,
Marra MA, Connors JM, Steidl C, Scott DW, Morin RD. Genome-wide
discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat Commun. 2018 Oct 1;9(1):4001.
PMCID: PMC6167379
4.
Duns
G, Viganò E, Ennishi D, Sarkozy C, Hung SS, Chavez E, Takata K, Rushton
C, Jiang A, Ben-Neriah S, Woolcock BW, Slack GW, Hsi ED, Craig JW,
Hilton LK, Shah SP, Farinha P, Mottok A, Gascoyne RD, Morin RD, Savage
KJ, Scott DW, Steidl C. Characterization of
DLBCL with a PMBL gene expression
signature. Blood. 2021 Jul 15;138(2):136–148.
5.
Rossi D, Deaglio S, Dominguez-Sola D, Rasi S,
Vaisitti T, Agostinelli C, Spina V, Bruscaggin A, Monti S, Cerri M,
Cresta S, Fangazio M, Arcaini L, Lucioni M, Marasca R, Thieblemont C,
Capello D, Facchetti F, Kwee I, Pileri SA, Foà R, Bertoni F,
Dalla-Favera R, Pasqualucci L, Gaidano G. Alteration of
BIRC3 and multiple other NF-κB
pathway genes in splenic marginal zone lymphoma. Blood. 2011 Nov
3;118(18):4930–4934.
6.
Lenz
G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W,
Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza
LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt
LM. Oncogenic
CARD11 mutations in human diffuse large B cell
lymphoma. Science. 2008 Mar;319(5870):1676–1679.
7.
Morin RD, Mendez-Lago M, Mungall AJ, Goya R,
Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M,
Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme
MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus
D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ,
Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao
Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J,
Horsman DE, Moore R, Jones SJM, Connors JM, Hirst M, Gascoyne RD, Marra
MA. Frequent mutation of histone-modifying genes in
non-Hodgkin lymphoma. Nature. 2011 Jul
27;476(7360):298–303. PMCID: PMC3210554
8.
Yan
Q, Huang Y, Watkins AJ, Kocialkowski S, Zeng N, Hamoudi RA, Isaacson PG,
de Leval L, Wotherspoon A, Du MQ. BCR and TLR
signaling pathways are recurrently targeted by genetic changes in
splenic marginal zone lymphomas. Haematologica. 2012 Apr;97(4):595–598.
PMCID: PMC3347666
9.
Desch AK, Hartung K, Botzen A, Brobeil A,
Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF,
Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald
M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW,
Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A,
Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider
DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz
R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A. Genotyping circulating
tumor DNA of pediatric Hodgkin lymphoma.
Leukemia. 2020 Jan;34(1):151–166.
10.
Grande BM, Gerhard DS, Jiang A, Griner NB,
Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K,
Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA,
Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL,
He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE,
Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG,
Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J,
Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH,
Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM. Genome-wide discovery
of somatic coding and noncoding mutations in pediatric endemic and
sporadic Burkitt lymphoma. Blood. 2019;133(12):1313–1324.
PMCID: PMC6428665
11.
Rossi D, Trifonov V, Fangazio M, Bruscaggin A,
Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Famà R, Ciardullo C,
Greco M, Cresta S, Piranda D, Holmes A, Fabbri G, Messina M, Rinaldi A,
Wang J, Agostinelli C, Piccaluga PP, Lucioni M, Tabbò F, Serra R,
Franceschetti S, Deambrogi C, Daniele G, Gattei V, Marasca R, Facchetti
F, Arcaini L, Inghirami G, Bertoni F, Pileri SA, Deaglio S, Foà R,
Dalla-Favera R, Pasqualucci L, Rabadan R, Gaidano G. The coding genome
of splenic marginal zone lymphoma: Activation of NOTCH2 and
other pathways regulating marginal zone development. J Exp Med. 2012 Aug
27;209(9):1537–1551. PMCID: PMC3428941
12.
Mansouri L, Noerenberg D, Young E, Mylonas E,
Abdulla M, Frick M, Asmar F, Ljungström V, Schneider M, Yoshida K,
Skaftason A, Pandzic T, Gonzalez B, Tasidou A, Waldhueter N,
Rivas-Delgado A, Angelopoulou M, Ziepert M, Arends CM, Couronné L, Lenze
D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J, Dörken B, Drexler HG,
Roos-Weil D, Schmitt CA, Munch-Petersen HD, Zenz T, Hansmann ML,
Strefford JC, Enblad G, Bernard OA, Ralfkiaer E, Erlanson M,
Korkolopoulou P, Hultdin M, Papadaki T, Grønbæk K, Lopez-Guillermo A,
Ogawa S, Küppers R, Stamatopoulos K, Stavroyianni N, Kanellis G,
Rosenwald A, Campo E, Amini RM, Ott G, Vassilakopoulos TP, Hummel M,
Rosenquist R, Damm F. Frequent
NFKBIE deletions are associated with poor outcome in
primary mediastinal B-cell lymphoma.
Blood. 2016 Dec 8;128(23):2666–2670.
13.
Morin RD, Assouline S, Alcaide M, Mohajeri A,
Johnston RL, Chong L, Grewal J, Yu S, Fornika D, Bushell K, Nielsen TH,
Petrogiannis-Haliotis T, Crump M, Tosikyan A, Grande BM, MacDonald D,
Rousseau C, Bayat M, Sesques P, Froment R, Albuquerque M, Monczak Y,
Oros KK, Greenwood C, Riazalhosseini Y, Arseneault M, Camlioglu E,
Constantin A, Pan-Hammarstrom Q, Peng R, Mann KK, Johnson NA. Genetic
Landscapes of Relapsed and Refractory
Diffuse Large B-Cell Lymphomas. Clin Cancer Res. 2016 May
1;22(9):2290–2300.
14.
Love C, Sun Z, Jima D, Li G, Zhang J, Miles R,
Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA,
Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM,
Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt
AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The
genetic landscape of mutations in Burkitt lymphoma. Nat
Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
15.
Pasqualucci L, Trifonov V, Fabbri G, Ma J,
Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J,
Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera
R. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet. 2011 Jul
31;43(9):830–837. PMCID: PMC3297422
16.
Zhang J, Grubor V, Love CL, Banerjee A,
Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G,
Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C,
Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A,
Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J,
Chadburn A, Levy S, Dunson D, Dave SS. Genetic heterogeneity of diffuse
large B-cell lymphoma. Proceedings of the
National Academy of Sciences of the United States of America.
2013;110:1398–1403. PMCID: PMC3557051
17.
Morin RD, Mungall K, Pleasance E, Mungall AJ,
Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC,
Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A,
Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL,
Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors
JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse
large B-cell lymphoma using whole-genome
sequencing. Blood. 2013 Aug 15;122(7):1256–1265. PMCID: PMC3744992
18.
Lohr JG, Stojanov P, Lawrence MS, Auclair D,
Chapuy B, Sougnez C, Cruz-Gordillo P, Knoechel B, Asmann YW, Slager SL,
Novak AJ, Dogan A, Ansell SM, Link BK, Zou L, Gould J, Saksena G,
Stransky N, Rangel-Escareño C, Fernandez-Lopez JC, Hidalgo-Miranda A,
Melendez-Zajgla J, Hernández-Lemus E, Schwarz-Cruz y Celis A,
Imaz-Rosshandler I, Ojesina AI, Jung J, Pedamallu CS, Lander ES,
Habermann TM, Cerhan JR, Shipp MA, Getz G, Golub TR. Discovery and
prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by
whole-exome sequencing. Proc Natl Acad Sci U S A. 2012 Mar
6;109(10):3879–3884. PMCID: PMC3309757
19.
Krysiak K, Gomez F, White BS, Matlock M, Miller
CA, Trani L, Fronick CC, Fulton RS, Kreisel F, Cashen AF, Carson KR,
Berrien-Elliott MM, Bartlett NL, Griffith M, Griffith OL, Fehniger TA.
Recurrent somatic mutations affecting B-cell
receptor signaling pathway genes in follicular lymphoma. Blood. 2017 Jan
26;129(4):473–483. PMCID: PMC5270390
20.
Richter J, Schlesner M, Hoffmann S, Kreuz M,
Leich E, Burkhardt B, Rosolowski M, Ammerpohl O, Wagener R, Bernhart SH,
Lenze D, Szczepanowski M, Paulsen M, Lipinski S, Russell RB, Adam-Klages
S, Apic G, Claviez A, Hasenclever D, Hovestadt V, Hornig N, Korbel JO,
Kube D, Langenberger D, Lawerenz C, Lisfeld J, Meyer K, Picelli S,
Pischimarov J, Radlwimmer B, Rausch T, Rohde M, Schilhabel M, Scholtysik
R, Spang R, Trautmann H, Zenz T, Borkhardt A, Drexler HG, Möller P,
MacLeod RAF, Pott C, Schreiber S, Trümper L, Loeffler M, Stadler PF,
Lichter P, Eils R, Küppers R, Hummel M, Klapper W, Rosenstiel P,
Rosenwald A, Brors B, Siebert R, ICGC MMML-Seq Project. Recurrent mutation of the
ID3 gene in Burkitt lymphoma identified by
integrated genome, exome and transcriptome sequencing. Nat Genet.
2012 Dec;44(12):1316–1320.
21.
Chapuy B, Stewart C, Dunford AJ, Kim J,
Kamburov A, Redd RA, Lawrence MS, Roemer MGM, Li AJ, Ziepert M, Staiger
AM, Wala JA, Ducar MD, Leshchiner I, Rheinbay E, Taylor-Weiner A,
Coughlin CA, Hess JM, Pedamallu CS, Livitz D, Rosebrock D, Rosenberg M,
Tracy AA, Horn H, van Hummelen P, Feldman AL, Link BK, Novak AJ, Cerhan
JR, Habermann TM, Siebert R, Rosenwald A, Thorner AR, Meyerson ML, Golub
TR, Beroukhim R, Wulf GG, Ott G, Rodig SJ, Monti S, Neuberg DS, Loeffler
M, Pfreundschuh M, Trümper L, Getz G, Shipp MA. Molecular subtypes of
diffuse large B cell lymphoma are associated with distinct
pathogenic mechanisms and outcomes. Nat Med. 2018 May;24(5):679–690.
PMCID: PMC6613387
22.
Tiacci E, Ladewig E, Schiavoni G, Penson A,
Fortini E, Pettirossi V, Wang Y, Rosseto A, Venanzi A, Vlasevska S,
Pacini R, Piattoni S, Tabarrini A, Pucciarini A, Bigerna B, Santi A,
Gianni AM, Viviani S, Cabras A, Ascani S, Crescenzi B, Mecucci C,
Pasqualucci L, Rabadan R, Falini B. Pervasive mutations of
JAK-STAT pathway genes in classical Hodgkin
lymphoma. Blood. 2018 May 31;131(22):2454–2465. PMCID: PMC6634958
23.
Wilda M, Bruch J, Harder L, Rawer D, Reiter A,
Borkhardt A, Woessmann W. Inactivation of the ARF-MDM-2-p53 pathway in sporadic
Burkitt’s lymphoma in children. Leukemia. 2004
Mar;18(3):584–588.
24.
Albuquerque MA, Grande BM, Ritch EJ,
Pararajalingam P, Jessa S, Krzywinski M, Grewal JK, Shah SP, Boutros PC,
Morin RD. Enhancing knowledge discovery from cancer genomics data with
Galaxy. Gigascience. 2017 May 1;6(5):1–13. PMCID: PMC5437943
25.
Beà
S, Valdés-Mas R, Navarro A, Salaverria I, Martín-Garcia D, Jares P, Giné
E, Pinyol M, Royo C, Nadeu F, Conde L, Juan M, Clot G, Vizán P, Croce
LD, Puente DA, López-Guerra M, Moros A, Roue G, Aymerich M, Villamor N,
Colomo L, Martínez A, Valera A, Martín-Subero JI, Amador V, Hernández L,
Rozman M, Enjuanes A, Forcada P, Muntañola A, Hartmann EM, Calasanz MJ,
Rosenwald A, Ott G, Hernández-Rivas JM, Klapper W, Siebert R, Wiestner
A, Wilson WH, Colomer D, López-Guillermo A, López-Otín C, Puente XS,
Campo E. Landscape of
somatic mutations and clonal evolution in mantle cell lymphoma.
PNAS. 2013;110(45):18250–18255.
26.
Zhang J, Jima D, Moffitt AB, Liu Q, Czader M,
Hsi ED, Fedoriw Y, Dunphy CH, Richards KL, Gill JI, Sun Z, Love C,
Scotland P, Lock E, Levy S, Hsu DS, Dunson D, Dave SS. The genomic
landscape of mantle cell lymphoma is related to the epigenetically
determined chromatin state of normal B cells. Blood.
2014 May 8;123(19):2988–2996.
27.
Pararajalingam P, Coyle KM, Arthur SE, Thomas
N, Alcaide M, Meissner B, Boyle M, Qureshi Q, Grande BM, Rushton C,
Slack GW, Mungall AJ, Tam CS, Agarwal R, Dawson SJ, Lenz G,
Balasubramanian S, Gascoyne RD, Steidl C, Connors J, Villa D, Audas TE,
Marra MA, Johnson NA, Scott DW, Morin RD. Coding and noncoding drivers
of mantle cell lymphoma identified through exome and genome sequencing.
Blood. 2020 Jul 30;136(5):572–584. PMCID: PMC7440974
28.
Challa-Malladi M, Lieu YK, Califano O, Holmes
AB, Bhagat G, Murty VV, Dominguez-Sola D, Pasqualucci L, Dalla-Favera R.
Combined genetic inactivation of Β2-Microglobulin and
CD58 reveals frequent escape from immune recognition in
diffuse large B cell lymphoma. Cancer Cell. 2011 Dec
13;20(6):728–740. PMCID: PMC3660995
29.
Reichel J, Chadburn A, Rubinstein PG,
Giulino-Roth L, Tam W, Liu Y, Gaiolla R, Eng K, Brody J, Inghirami G,
Carlo-Stella C, Santoro A, Rahal D, Totonchy J, Elemento O, Cesarman E,
Roshal M. Flow
sorting and exome sequencing reveal the oncogenome of primary
Hodgkin and Reed-Sternberg cells. Blood.
2015 Feb 12;125(7):1061–1072.
30.
Nadeu F, Martín-García D, Clot G, Díaz-Navarro
A, Duran-Ferrer M, Navarro A, Vilarrasa-Blasi R, Kulis M, Royo R,
Gutiérrez-Abril J, Valdés-Mas R, López C, Chapaprieta V, Puiggrós M,
Castellano G, Costa D, Aymerich M, Jares P, Espinet B, Muntañola A,
Ribera‐Cortada I, Siebert R, Colomer D, Torrents D, Giné E,
López-Guillermo A, Küppers R, Martín-Subero J, Puente X, Beà S, Campo E.
Genomic and
epigenomic insights into the origin, pathogenesis and clinical behavior
of mantle cell lymphoma subtypes. Blood. 2020;
31.
Jallades L, Baseggio L, Sujobert P, Huet S,
Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado
D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles
G, Traverse-Glehen A. Exome sequencing identifies recurrent
BCOR alterations and the absence of KLF2,
TNFAIP3 and MYD88 mutations in splenic diffuse
red pulp small B-cell lymphoma.
Haematologica. 2017 Oct;102(10):1758–1766. PMCID: PMC5622860
32.
Parry M, Rose-Zerilli MJJ, Gibson J, Ennis S,
Walewska R, Forster J, Parker H, Davis Z, Gardiner A, Collins A, Oscier
DG, Strefford JC. Whole exome sequencing identifies novel recurrently
mutated genes in patients with splenic marginal zone lymphoma. PLoS One.
2013;8(12):e83244. PMCID: PMC3862727
33.
Sarkozy C, Hung SS, Chavez EA, Duns G, Takata
K, Chong LC, Aoki T, Jiang A, Miyata-Takata T, Telenius A, Slack GW,
Molina TJ, Ben-Neriah S, Farinha P, Dartigues P, Damotte D, Mottok A,
Salles GA, Casasnovas RO, Savage KJ, Laurent C, Scott DW,
Traverse-Glehen A, Steidl C. Mutational landscape of
gray zone lymphoma. Blood. 2021 Apr 1;137(13):1765–1776.
34.
Zhou P, Blain AE, Newman AM, Zaka M, Chagaluka
G, Adlar FR, Offor UT, Broadbent C, Chaytor L, Whitehead A, Hall A,
O’Connor H, Van Noorden S, Lampert I, Bailey S, Molyneux E, Bacon CM,
Bomken S, Rand V. Sporadic and endemic Burkitt lymphoma
have frequent FOXO1 mutations but distinct hotspots in the
AKT recognition motif. Blood Adv. 2019 Jul
23;3(14):2118–2127. PMCID: PMC6650741
35.
Spina V, Khiabanian H, Messina M, Monti S,
Cascione L, Bruscaggin A, Spaccarotella E, Holmes AB, Arcaini L, Lucioni
M, Tabbò F, Zairis S, Diop F, Cerri M, Chiaretti S, Marasca R, Ponzoni
M, Deaglio S, Ramponi A, Tiacci E, Pasqualucci L, Paulli M, Falini B,
Inghirami G, Bertoni F, Foà R, Rabadan R, Gaidano G, Rossi D. The
genetics of nodal marginal zone lymphoma. Blood. 2016 Sep
8;128(10):1362–1373. PMCID: PMC5016706
Citing
If you use the information or data from this site, please cite
Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.
